LEADING BIOSCIENCES, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 23rd, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledDecember 23rd, 2020 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is made and entered into effective as of December 16, 2020 (the “Effective Date”), by and between JD Finley (“Executive”) and Leading BioSciences, Inc. (the “Company”).
CO-DEVELOPMENT AND DISTRIBUTION AGREEMENTDevelopment and Distribution Agreement • December 23rd, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledDecember 23rd, 2020 Company IndustryThis Co-Development and Distribution Agreement (this “Agreement”) is made and entered into as of the 27th day of February, 2018 (the “Effective Date”) by and between Leading BioSciences, Inc., a corporation organized under the laws of Delaware having its office at 5800 Armada Drive, Ste. 210, Carlsbad, CA 92008 (“LBS”), and Biolead Medical Technology Limited, a limited company organized under the laws of the Hong Kong. LBS and Newsoara (defined below) are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
LICENSE AGREEMENT BETWEEN LEADING BIOSCIENCES, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR CASE NO. […***…] CASE NO. […***…]License Agreement • December 23rd, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledDecember 23rd, 2020 Company Industry JurisdictionThis agreement (“Agreement”) is made by and between Leading BioSciences, Inc., a Delaware corporation having an address at 5800 Armada Dr, Suite 210, Carlsbad, California 92008 (“LICENSEE”) and The Regents of the University of California, a California public corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200 (“UNIVERSITY”), represented by its San Diego campus having an address at University of California San Diego, Office of Innovation and Commercialization, Mail Code 0910, 9500 Gilman Drive, La Jolla, California 92093-0910 (“UC San Diego”).
LICENSE AGREEMENT BETWEEN LEADING BIOSCIENCES, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR CASE NO. […***…]License Agreement • December 23rd, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledDecember 23rd, 2020 Company Industry JurisdictionThis agreement (“Agreement”) is made by and between Leading Biosciences, a California corporation having an address at 3580 Carmel Mountain Road, San Diego, CA 92130 (“LICENSEE”) and The Regents of the University of California, a California public corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200 (“UNIVERSITY”), represented by its San Diego campus having an address at University of California, San Diego, Technology Transfer Office, Mail Code 0910, 9500 Gilman Drive, La Jolla, California 92093-0910 (“UCSD”).